# Fu Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/fu-bioscience

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Latest round: Series A (Aug 25, 2023)
- Investors on record: 2

## About

Based in Shanghai, China and founded in 2021, Fu Bioscience operates as a medical robot developer specializing in microsurgical machinery for head and neck and above. In Janurary 2022, the company completed a strategic investment from new investor Dalton Venture. In August 2023, it raised a series A funding led by new investor Hongshan, with participation from returning investor Dalton Venture.

Fu Bioscience takes the surgical robot as the core, and develops and builds microsurgical instruments around minimally invasive surgery. The company's main product is a humanoid dual-arm robot with macro-micro control that can be used for microsurgery above the head and neck.

## Funding rounds

- Series A, Aug 25, 2023 — Dalton Venture, HSG

## Investors

- Dalton Venture (https://capitalatlas.ai/funds/dalton-venture) — Series A
- HSG (https://capitalatlas.ai/funds/hsg) — Series A